Cary Street Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.4M Buy
139,478
+811
+0.6% +$189K 0.77% 24
2026
Q1
$33.9M Sell
138,667
-769
-0.6% -$179K 0.84% 25
2025
Q4
$28.9M Buy
139,436
+7,367
+6% +$1.46M 0.71% 30
2025
Q3
$24.5M Buy
132,069
+1,103
+0.8% +$189K 0.64% 33
2025
Q2
$20M Buy
130,966
+1,001
+0.8% +$154K 0.56% 38
2025
Q1
$21.6M Buy
129,965
+17,510
+16% +$2.74M 0.68% 28
2024
Q4
$16.3M Buy
+112,455
New +$17.4M 0.53% 45

Other funds holding JNJ

Cary Street Partners's JNJ Position: Q2 2026 in Review

Cary Street Partners increased its Johnson & Johnson (JNJ) stake by 0.58% in Q2 2026, buying an estimated $189K and bringing the position to 139,478 shares worth $35.4M. The position accounts for 0.77% of the portfolio, ranked #24.

Cary Street Partners first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cary Street Partners held 139,478 shares of Johnson & Johnson worth $35.4M as of Q2 2026.
  • Cary Street Partners bought 811 Johnson & Johnson shares in Q2 2026, an estimated $189K.
  • Johnson & Johnson made up 0.77% of Cary Street Partners's portfolio in Q2 2026, its #24 holding.
  • Cary Street Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.